These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Factors associated with detection of human papillomavirus E4 and L1 proteins in condylomata acuminata. Brown DR; Bryan JT; Rodriguez M; Katz BP J Infect Dis; 1992 Sep; 166(3):512-7. PubMed ID: 1323617 [TBL] [Abstract][Full Text] [Related]
63. Juvenile-onset recurrent respiratory papillomatosis with pulmonary involvement and carcinomatous transformation. Mitsumoto GL; Bernardi FDC; Paes JF; Villa LL; Mello B; Pozzan G Autops Case Rep; 2018; 8(3):e2018035. PubMed ID: 30101139 [TBL] [Abstract][Full Text] [Related]
64. Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis. Kashima HK; Kessis T; Mounts P; Shah K Otolaryngol Head Neck Surg; 1991 Feb; 104(2):191-5. PubMed ID: 1848926 [TBL] [Abstract][Full Text] [Related]
65. [Prevalence of human papilloma virus types and their influence on the course of the disease in children suffering from recurrent respiratory papillomatosis]. Obchinnikov IuM; Kiselev VI; Soldatskiĭ IuL; Artem'ev MI; Onufrieva EK; Baranovskiĭ PM; Shchepin NV; Smetanina SE; Gasparian SF; Steklov AM Vestn Otorinolaringol; 2004; (3):29-33. PubMed ID: 15159735 [TBL] [Abstract][Full Text] [Related]
66. Current concepts on human papillomavirus infections in children. Syrjänen S APMIS; 2010 Jun; 118(6-7):494-509. PubMed ID: 20553530 [TBL] [Abstract][Full Text] [Related]
67. Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls. Cubie HA; Plumstead M; Zhang W; de Jesus O; Duncan LA; Stanley MA J Med Virol; 1998 Nov; 56(3):210-6. PubMed ID: 9783687 [TBL] [Abstract][Full Text] [Related]
68. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444 [TBL] [Abstract][Full Text] [Related]
69. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. Omland T; Akre H; Vårdal M; Brøndbo K Laryngoscope; 2012 Jul; 122(7):1595-9. PubMed ID: 22565595 [TBL] [Abstract][Full Text] [Related]
70. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women. Svare EI; Kjaer SK; Nonnenmacher B; Worm AM; Moi H; Christensen RB; van den Brule AJ; Walboomers JM; Meijer CJ; Hubbert NL; Lowy DR; Schiller JT J Infect Dis; 1997 Oct; 176(4):876-83. PubMed ID: 9333144 [TBL] [Abstract][Full Text] [Related]
71. Seroresponses to virus-like particles of human papillomavirus types 16, 18, 31, 33, and 45 in San people of Southern Africa. Marais D; Rose RC; Lane C; Aspinall S; Bos P; Williamson AL J Med Virol; 2000 Mar; 60(3):331-6. PubMed ID: 10630966 [TBL] [Abstract][Full Text] [Related]
72. Recurrent respiratory papillomatosis: clinical characteristics and viral genotyping in a Brazilian population. Carvalho AMAS; Brito DS; Cunha APA; Monteiro PM; Ferreira MB; Assis DSFR; Bentivi JO; Andrade MS; Vidal FCB; Salgado Filho N Rev Inst Med Trop Sao Paulo; 2021; 63():e63. PubMed ID: 34406288 [TBL] [Abstract][Full Text] [Related]
73. Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. Mounts P; Kashima H Laryngoscope; 1984 Jan; 94(1):28-33. PubMed ID: 6318005 [TBL] [Abstract][Full Text] [Related]
74. Current and future management of recurrent respiratory papillomatosis. Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L Laryngoscope Investig Otolaryngol; 2018 Feb; 3(1):22-34. PubMed ID: 29492465 [TBL] [Abstract][Full Text] [Related]
75. Association between human papillomavirus particle production and the severity of recurrent respiratory papillomatosis. Yamada S; Itoh T; Ikegami T; Imai A; Mochizuki D; Nakanishi H; Ishikawa R; Kita J; Nakamura Y; Takizawa Y; Okamura J; Noda Y; Iwashita T; Hariyama T; Suzuki M; Misawa K; Kawasaki H Sci Rep; 2023 Apr; 13(1):5514. PubMed ID: 37024540 [TBL] [Abstract][Full Text] [Related]
76. [Laryngeal Recurrent Respiratory Papillomatosis: Current Aspects on Diagnosis and Therapy]. Langer C; Wittekindt C; Wolf G Laryngorhinootologie; 2019 Aug; 98(8):577-587. PubMed ID: 31387134 [TBL] [Abstract][Full Text] [Related]
77. Comparative sensitivity of the immunoelectronmicroscopy test and ELISA with intact virions in detecting HPV-1 antibodies and age distribution of these antibodies among general population and in children's homes. Anisimová E; Barták P; Hamsiková E; Vonka V Arch Virol; 1994; 137(1-2):157-60. PubMed ID: 7979989 [TBL] [Abstract][Full Text] [Related]
78. Characterization of proteins of human papilloma viruses (HPV) and antibody response to HPV 1. Pfister H; zur Hausen H Med Microbiol Immunol; 1978 Nov; 166(1-4):13-9. PubMed ID: 214677 [TBL] [Abstract][Full Text] [Related]
79. Clinical characteristics and HPV type in recurrent respiratory papillomatosis in Colombia. Cuello G; Sánchez GI; Jaramillo R; Quintero K; Baena A; O'Byrne A; Reyes AJ; Santamaría C; Reina JC; Muñoz N Salud Publica Mex; 2013 Aug; 55(4):416-20. PubMed ID: 24165718 [TBL] [Abstract][Full Text] [Related]
80. Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP). Israr M; DeVoti JA; Lam F; Abramson AL; Steinberg BM; Bonagura VR Front Immunol; 2020; 11():336. PubMed ID: 32210959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]